Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 6789.73% ano a ano.
Em Crescimento
A empresa está em fase de crescimento, com a receita anual mais recente totalizando US$ 615.87K.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 615.87K.
Avaliação Justa
O PE mais recente da empresa é -0.62, em uma faixa percentil média de 3 anos.
Compra Institucional
As participações institucionais mais recentes são de 292.25K ações, um aumento de 33.05% em relação ao trimestre anterior.
Mantido por James Simons
O Super Investidor James Simons possui 31.00K ações desta empresa.